New drug VNA-318 tested for safety in healthy volunteers
Knowledge-focused
Completed
This early-phase trial tested the safety and tolerability of a new drug called VNA-318 in 92 healthy men. Participants received either a single or multiple doses of the drug or a placebo. The main goal was to check for side effects and understand how the drug moves through the bo…
Phase: PHASE1 • Sponsor: VANDRIA • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC